Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care of patients living with rare genetic diseases of obesity. Rare genetic diseases of obesity have two hallmark symptoms, early onset obesity and insatiable hunger, also known as hyperphagia.  They may be diagnosed with genetic testing.  You can learn more about rare genetic diseases of obesity at https://www.leadforrareobesity.com/ and genetic testing at https://uncoveringrareobesity.com/patient/.

Company Email Address: [email protected]